Publication | Closed Access

Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation

Hematological MalignancyCell TherapyTransplantationMarrow TransplantationMedicineRelapsed Myeloid MalignanciesMalignant Blood DisorderImmunologyHematologyHigher Leukemic BurdenBlood TransplantationOncologyCell TransplantationDonor Lymphocyte InfusionsMyeloid Neoplasia